Literature DB >> 10524968

Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intra-abdominal infection: relation to nasal colonization.

L Fierobe1, D Decré, C Mùller, J C Lucet, J P Marmuse, J Mantz, J M Desmonts.   

Abstract

In the surgical intensive care unit of a university hospital, we investigated the frequency of and the risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) during postoperative intra-abdominal infection (pIAI). We conducted a prospective MRSA nasal screening and case evaluation for 17 months among 73 consecutive patients with having pIAI. MRSA pIAI was diagnosed when MRSA was obtained from culture of intraperitoneal fluids. The identity of nasal and peritoneal MRSA strains was assessed by genomic analysis. Twelve patients had MRSA pIAI, representing 21% of all MRSA infections acquired by the 73 patients. An organ system failure score of >/=1 and MRSA nasal carriage prior to pIAI were the independent risk factors for acquisition of MRSA pIAI. Patients with MRSA pIAI had a longer intensive care unit stay and more reoperations than did those free of MRSA pIAI. We conclude that MRSA may be a causative pathogen in pIAI and may be related to nasal colonization.

Entities:  

Mesh:

Year:  1999        PMID: 10524968     DOI: 10.1086/313454

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

Review 1.  Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit.

Authors:  A S Haddadin; S A Fappiano; P A Lipsett
Journal:  Postgrad Med J       Date:  2002-07       Impact factor: 2.401

2.  Does dual antibiotic prophylaxis better prevent surgical site infections in total joint arthroplasty?

Authors:  Amy Sewick; Amun Makani; Chia Wu; Judith O'Donnell; Keith D Baldwin; Gwo-Chin Lee
Journal:  Clin Orthop Relat Res       Date:  2012-10       Impact factor: 4.176

3.  Canadian practice guidelines for surgical intra-abdominal infections.

Authors:  Anthony W Chow; Gerald A Evans; Avery B Nathens; Chad G Ball; Glen Hansen; Godfrey Km Harding; Andrew W Kirkpatrick; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

4.  Can Nasal Methicillin-Resistant Staphylococcus aureus Screening Be Used to Avoid Empiric Vancomycin Use in Intra-Abdominal Infection?

Authors:  Sara A Hennessy; Puja M Shah; Christopher A Guidry; Stephen W Davies; Tjasa Hranjec; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2015-06-12       Impact factor: 2.150

5.  Bacterial and host factors implicated in nasal carriage of methicillin-resistant Staphylococcus aureus in mice.

Authors:  Bruno González-Zorn; Jose P M Senna; Laurence Fiette; Spencer Shorte; Aurélie Testard; Michel Chignard; Patrice Courvalin; Catherine Grillot-Courvalin
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model.

Authors:  John F Kokai-Kun; Scott M Walsh; Tanya Chanturiya; James J Mond
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

7.  Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus.

Authors:  H Watanabe; H Masaki; N Asoh; K Watanabe; K Oishi; S Kobayashi; A Sato; R Sugita; T Nagatake
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

8.  Impact of Probiotics for Reducing Infections in Veterans (IMPROVE): Study protocol for a double-blind, randomized controlled trial to reduce carriage of Staphylococcus aureus.

Authors:  Shoshannah Eggers; Anna Barker; Susan Valentine; Timothy Hess; Megan Duster; Nasia Safdar
Journal:  Contemp Clin Trials       Date:  2016-11-09       Impact factor: 2.226

9.  Molecular analysis of methicillin-resistant Staphylococcus aureus as a causative agent of bronchopulmonary infection: relation to colonization in the upper respiratory tract.

Authors:  H Watanabe; H Masaki; N Asoh; K Watanabe; K Oishi; S Kobayashi; A Sato; T Nagatake
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

10.  Neomycin Sulfate Improves the Antimicrobial Activity of Mupirocin-Based Antibacterial Ointments.

Authors:  Catlyn Blanchard; Lauren Brooks; Andrew Beckley; Jennifer Colquhoun; Stephen Dewhurst; Paul M Dunman
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.